Cointime

Peroxitech Therapeutics

company

About

Peroxitech Therapeutics operates as a biopharmaceutical company.

Highlights

Total Funding Amount
$25M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Series A
Last Funding Money Raised
$25M
Industries
Biopharma,Biotechnology,Health Care,Medical
Founded date
Jan 1, 2016
Operating Status
Active

Peroxitech Therapeutics operates as a biopharmaceutical company developing PIP-2 to reverse acute lung injury (ALI) by targeting the cytokine storm cascade process.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$25M
Peroxitech Therapeutics has raised a total of $25M in funding over 2 rounds. Their latest funding was raised on Dec 13, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 13, 2022 Series A $25M 1 Xontogeny — Detail
May 12, 2021 Seed — 1 Xontogeny — Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Peroxitech Therapeutics is funded by 1 investors. Xontogeny are the most recent investors.
Investor Name Lead Investor Funding Round
Xontogeny Yes Series A
Cointime
เนื้อหา
บริษัท